165 related articles for article (PubMed ID: 9720504)
1. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells.
Kanavaros P; Briere J; Lescs MC; Gaulard P
J Pathol; 1996 Mar; 178(3):297-302. PubMed ID: 8778335
[TBL] [Abstract][Full Text] [Related]
4. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan.
Tomita Y; Ohsawa M; Mishiro Y; Kubo T; Maeshiro N; Kojya S; Noda Y; Aozasa K
Lab Invest; 1995 Aug; 73(2):190-6. PubMed ID: 7637319
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China.
van Gorp J; Weiping L; Jacobse K; Liu YH; Li FY; De Weger RA; Li G
J Pathol; 1994 Jun; 173(2):81-7. PubMed ID: 7522272
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
[TBL] [Abstract][Full Text] [Related]
9. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
Mori N; Yatabe Y; Oka K; Kinoshita T; Kobayashi T; Ono T; Asai J
Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
[TBL] [Abstract][Full Text] [Related]
10. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
11. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection.
Arber DA; Weiss LM; Albújar PF; Chen YY; Jaffe ES
Am J Surg Pathol; 1993 Apr; 17(4):392-9. PubMed ID: 8388175
[TBL] [Abstract][Full Text] [Related]
12. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype.
de Bruin PC; Jiwa NM; Oudejans JJ; Radaszkiewicz T; Meijer CJ
Am J Pathol; 1995 Apr; 146(4):861-7. PubMed ID: 7717453
[TBL] [Abstract][Full Text] [Related]
14. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
Tao Q; Srivastava G; Dickens P; Ho FC
Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
17. In situ detection of activated cytotoxic cells in follicular lymphomas.
Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
[TBL] [Abstract][Full Text] [Related]
18. [Clinical, phenotypic and genotypic aspects of nasal T-cell lymphoma and its causal association with Epstein-Barr virus].
Harabuchi Y; Imai S; Kataura A; Osato T
Nihon Rinsho; 1997 Feb; 55(2):394-9. PubMed ID: 9046830
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
20. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]